Nephros (NEPH) Retained Earnings (2010 - 2026)

Nephros' Retained Earnings history runs 17 years deep, the most recent figure standing at -$143.0 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 0.54% year-over-year to -$143.0 million in Q1 2026; TTM through Mar 2026 was -$143.0 million, a 0.54% increase from a year earlier, with the FY2025 full-year figure at $153.3 million, up 206.23% from the prior year.
• Retained Earnings retreated to -$143.0 million in Q1 2026 per NEPH's latest filing, from $153.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at $153.3 million in Q4 2025 and bottomed at -$144.9 million in Q2 2024.
• The 5-year median for Retained Earnings is -$143.1 million (2023), against an average of -$73.5 million.
• Biggest YoY gain for Retained Earnings was 231795.31% in 2022; the steepest drop was 215225.76% in 2022.
• Year by year, Retained Earnings stood at $148.4 million in 2022, then tumbled by 197.3% to -$144.4 million in 2023, then grew by 0.05% to -$144.3 million in 2024, then soared by 206.23% to $153.3 million in 2025, then plunged by 193.26% to -$143.0 million in 2026.
• Per Business Quant, the three latest NEPH Retained Earnings figures stand at -$143.0 million (Q1 2026), $153.3 million (Q4 2025), and $153.2 million (Q3 2025).